Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
4 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Mirum Pharmaceuticals, Inc.’s names, not what it holds today.
Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and none in 2023
Applications published
18
3 of them in 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name1 counted
Mirum Pharmaceuticals, Inc. its own name
US, as the owner printed on each patent
18 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 13, 2025 | 12,296,050 | Pharmaceutical compositions comprising maralixibat and uses thereof | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Mar 5, 2024 | 11,918,578 | Methods for treating cholestasis | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Nov 15, 2022 | 11,497,745 | Methods for treating cholestasis | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Jan 25, 2022 | 11,229,647 | Methods for treating cholestasis | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 27, 2025 | 2025/0360127 | METHODS FOR TREATING CHOLESTASIS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Nov 13, 2025 | 2025/0345326 | METHODS FOR TREATING CHOLESTATIC PRURITUS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Apr 10, 2025 | 2025/0114310 | PHARMACEUTICAL COMPOSITIONS COMPRISING MARALIXIBAT AND USES THEREOF | Pharmaceuticals | Mirum Pharmaceuticals, Inc. · patent 12,296,050 granted from it |
| Nov 21, 2024 | 2024/0382507 | PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,4,5- TETRAHYDROBENZOTHIEPIN- 1,1-DIOXIDE DERIVATIVES AND THE USE THEREOF | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Jun 27, 2024 | 2024/0207260 | METHODS FOR TREATING CHOLESTASIS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Jun 13, 2024 | 2024/0189308 | METHODS FOR TREATING CHOLESTASIS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| May 30, 2024 | 2024/0173317 | METHODS FOR TREATING PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Apr 11, 2024 | 2024/0116891 | MARALIXIBAT SOLID FORMS, INTERMEDIATES AND PROCESSES OF MAKING SAME | Organic fine chemistry | Mirum Pharmaceuticals, Inc. |
| Jun 22, 2023 | 2023/0190743 | TREATMENT WITH ILEAL BILE ACID TRANSPORTER (IBAT) INHIBITORS FOR INCREASED EVENT-FREE SURVIVAL (EFS) | Pharmaceuticals | Mirum Pharmaceuticals, Inc. |
| Jun 22, 2023 | 2023/0190742 | METHODS FOR TREATING CHOLESTASIS | Pharmaceuticals | Mirum Pharmaceuticals, Inc. · patent 11,918,578 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 7 · Organic fine chemistry 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.